Newsfeeds Archive - Spark Newswire

2 minute read

Entera Bio Announces Publication Of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data I1n The Journal Of Bone And Mineral Research

April 8, 8:33 AM

Entera Bio Ltd. (NASDAQ:ENTX), ("Entera" or the "Company") a leader in the development of orally delivered peptides, announced today that data from the Phase 2 Trial of its lead clinical compound, EB613 (Oral PTH(1-34)

ENTX

2 minute read

Entera Bio And 3 Other Stocks Under $1 Insiders Are Buying

By Avi Kapoor

January 12, 8:48 AM

The Dow Jones index closed slightly higher on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

ENTX

2 minute read

Interim Results From Ongoing Clinical Study Confirm EB613 Optimized Profile For Osteoporosis Treatment And Potential For Entera’s Next Generation Oral Peptide Platform

By Benzinga Newsdesk

November 29, 9:33 AM

Entera Bio Ltd. (NASDAQ:ENTX), ("Entera" or the "Company") a leader in the development of orally delivered peptides and therapeutic proteins, reported today interim data from an ongoing Phase 1 study designed to assess

ENTX

3 minute read

Entera Bio Reports Rapid Pharmacodynamic Response And Consistent Pharmacokinetic Data For Its First-In-Class Oral PTH(1-34) Mini Tablets At The ASBMR 2023 Annual Meeting

By Benzinga Newsdesk

October 16, 8:20 AM

Entera Bio Ltd. (NASDAQ:ENTX), ("Entera" or the "Company") a leader in the development of orally delivered peptides and therapeutic proteins, presented 2 posters at the Annual Society of Bone and Mineral Research (ASBMR)

ENTX

2 minute read

Bioventus And 3 Other Stocks Under $5 Insiders Are Buying

By Lisa Levin

August 23, 9:23 AM

The Dow Jones closed lower by 175 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

BVS

1 minute read

Earnings

Entera Bio: Q1 Earnings Insights

By Benzinga Insights

May 5, 4:10 PM

Entera Bio (NASDAQ:ENTX) reported its Q1 earnings results on Friday, May 5, 2023 at 04:05 PM. Here’s what…

ENTX

2 minute read

Reported Earlier, Entera Bio Provides Guidance From FDA Type D Meeting Related To EB613 Pivotal Program

By Happy Mohamed

April 3, 8:18 AM

Entera Bio Ltd. (NASDAQ:ENTX) ("Entera" or the "Company") a leader in the development of orally delivered peptides and therapeutic proteins, today announced feedback from its Type D Meeting with the

ENTX

1 minute read

News

Entera Bio Regains Compliance With Nasdaq Listing Requirements

By Happy Mohamed

March 23, 9:48 AM

Entera Bio Ltd. (NASDAQ:ENTX), ("Entera" or the "Company") a leader in the development of orally delivered peptides and therapeutic proteins, announced today that it received notice from The

ENTX

2 minute read

Why Oblong Shares Are Trading Higher By 59%; Here Are 20 Stocks Moving Premarket

By Lisa Levin

January 4, 8:59 AM

Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares rose 63.2% to $0.4201 in pre-market trading after dropping 8% on Tuesday. Elys Game Technology and Cloakbook were recently granted a license to commence sportsbook operations in Washington, D.C.

ARBK

6 minute read

Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday

By Lisa Levin

November 14, 3:35 AM

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday.